Trademarkia Logo

Australia

AU$
Trademark Search
FOCUS. TAKEN IN. OPTIMIZE.

View On IPO.GOV.AU

FOCUS. TAKEN IN. OPTIMIZE.
Cancelled: Cancelled at the request of IB

Last updated on 14 Mar 2023

Owner Info

Antipodean Pharmaceuticals Inc.

c/o Seed IP Law Group LLP

701 Fifth Avenue, Suite 5400, UNITED STATES OF AMERICA

Serial Number

2239920 filed on 30 Nov 2021

Correspondent

Syed Abedi

Seed IP Law Group LLP,,

701 5th Avenue, Suite 5400,

UNITED STATES OF AMERICA

FOCUS. TAKEN IN. OPTIMIZE.

Classification Information

Class [005]
Pharmaceutical preparations, namely, antioxidants targeting mitochondria; dietary supplements.

Mark Details

Serial Number

2239920

Registered On

30 Nov 2021

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

11 Jun 2021

Mark Type

US

Legal History

Show more

Status DateAction Taken
14th Mar 2023Status change to Voided
9th Mar 2023International Registration - Correction Received
23rd Mar 2022International Registration in Australia Protected correspondence sent
22nd Mar 2022IP Right Registration Published
22nd Mar 2022Status change to Registered/Protected
15th Jan 2022Application Accepted correspondence sent
14th Jan 2022IP Right has been Examined
14th Jan 2022IP Right Acceptance Published
14th Jan 2022Status change to Accepted
4th Jan 2022Awaiting examination